Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine

Table 3 Treatment response to NAC by histopathology

From: Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

 

Histopathology

n

%

CR

22

15.5

Non-CR

  PR

58

40.8

  SD

48

33.8

  PD

14

9.9

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, n number
Back to article page